GlaxoSmithKline PLC (NYSE:GSK)

U.S. Markets are not yet open, but GSK is being traded in the pre-market session. Pre-Market quote »
49.10
Data as of Aug 29
 +0.23 / +0.47%
Today’s Change
46.01
Today|||52-Week Range
56.73
-8.04%
Year-to-Date

Stock Price Forecast

The 24 analysts offering 12-month price forecasts for GlaxoSmithKline PLC have a median target of 53.42, with a high estimate of 63.63 and a low estimate of 45.75. The median estimate represents a +8.79% increase from the last price of 49.10.

Analyst Recommendations

The current consensus among 28 polled investment analysts is to Hold stock in GlaxoSmithKline PLC. This rating has held steady since September, when it was unchanged from a Hold rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
$0.81
Sales
$9.8B
Reporting Date
Oct 22

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 25.12%
 
 
 
 
 
 
Growthannually -13.05%
 
 
 
 
 
 

Sales

Growthquarterly 3.75%
 
 
 
 
 
 
Growthannually -8.63%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.

To view my watchlist

Not a member yet?

Sign up now for a free account
Market indexes are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer Morningstar: © 2014 Morningstar, Inc. All Rights Reserved. Disclaimer The Dow Jones IndexesSM are proprietary to and distributed by Dow Jones & Company, Inc. and have been licensed for use. All content of the Dow Jones IndexesSM © 2014 is proprietary to Dow Jones & Company, Inc. Chicago Mercantile Association. The market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved. FactSet Research Systems Inc. 2014. All rights reserved. Most stock quote data provided by BATS.